Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study.
Lancet. 2024 Oct 5;404(10460):1309-1320. doi: 10.1016/S0140-6736(24)01758-6. Epub 2024 Sep 13.
Lancet. 2024.
PMID: 39284329
Clinical Trial.
Childhood health and nutrition challenges in Sudan's conflict zones.
Hassan IN, Abuassa N, Ibrahim M.
Hassan IN, et al.
Lancet. 2024 Sep 28;404(10459):1193. doi: 10.1016/S0140-6736(24)01911-1. Epub 2024 Sep 13.
Lancet. 2024.
PMID: 39284328
No abstract available.
Item in Clipboard
Mpox and breastmilk: for once, can we act in time?
Imani-Musimwa P, Ververs M.
Imani-Musimwa P, et al.
Lancet. 2024 Sep 28;404(10459):1191. doi: 10.1016/S0140-6736(24)01881-6. Epub 2024 Sep 13.
Lancet. 2024.
PMID: 39284327
No abstract available.
Item in Clipboard
Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma.
Yochum ZA, Braun DA.
Yochum ZA, et al.
Lancet. 2024 Oct 5;404(10460):1280-1282. doi: 10.1016/S0140-6736(24)01866-X. Epub 2024 Sep 13.
Lancet. 2024.
PMID: 39284326
No abstract available.
Item in Clipboard
Cite
Cite